Fujirebio makes biomarkers (i.e., blood tests) and its core competency is in the oncology area so its products are mainly centered around cancer testing. The product it manufactures annually is quite considerable. At their Malvern, Pennsylvania plant, they produce about 75 million tests that are then distributed throughout the world.
The solution is completely paperless and provides electronic record collection with electronic signatures while maintaining 21 CFR compliance and ISO 9001 and 13485 certification